Dormant Company Accounts - THE CLINICAL COMPENSATION COMPANY LIMITED

Dormant Company Accounts - THE CLINICAL COMPENSATION COMPANY LIMITED


Companies House true 2022-10-01 2023-09-30 false 04740265 uk-bus:Director1 2022-10-01 2023-09-30 04740265 uk-bus:Director2 2022-10-01 2023-09-30 04740265 2022-10-01 2023-09-30 04740265 2023-09-30 04740265 uk-bus:EntityHasNeverTraded 2022-10-01 2023-09-30 04740265 uk-bus:FRS102 2022-10-01 2023-09-30 04740265 uk-bus:FullAccounts 2022-10-01 2023-09-30 04740265 uk-bus:AuditExempt-NoAccountantsReport 2022-10-01 2023-09-30 04740265 2022-09-30 04740265 uk-bus:OrdinaryShareClass1 2022-10-01 2023-09-30 04740265 uk-bus:OrdinaryShareClass2 2022-10-01 2023-09-30 04740265 uk-bus:OrdinaryShareClass3 2022-10-01 2023-09-30 04740265 uk-bus:PreferenceShareClass1 2022-10-01 2023-09-30 04740265 uk-bus:PreferenceShareClass2 2022-10-01 2023-09-30 04740265 uk-bus:PreferenceShareClass3 2022-10-01 2023-09-30 04740265 uk-core:ShareCapitalPreferenceShares 2023-09-30 04740265 uk-core:ShareCapitalPreferenceShares 2022-09-30 iso4217:GBP xbrli:shares

Registered Number 04740265

THE CLINICAL COMPENSATION COMPANY LIMITED

Dormant Accounts

30 September 2023

THE CLINICAL COMPENSATION COMPANY LIMITED Registered Number 04740265

Balance Sheet as at 30 September 2023

2023 2022
£ £
Called up share capital not paid
300
300
Net assets
300
300
Issued share capital
300 Ordinary Shares of £ 1 each 300 300
Total Shareholder funds
300
300

STATEMENTS

  1. For the year ending 30 September 2023 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 17 October 2023

And signed on their behalf by:
Richard Forth, Director